Cell response induced by internalized bacterial magnetic nanoparticles under an external static magnetic field

Biomaterials

Volumn 33, Issue 22, 2012, Pages 5650-5657

  Shin, Jaeha ^a   Yoo, Chang Hyuk ^a   Lee, Junghoon ^a,b   Cha, Misun ^b  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Antiapoptosis; Bacterial magnetic nanoparticles (BMPs); Magnetic field; Microarray; Proliferation

Indexed keywords

ANTI-APOPTOSIS; ANTICANCER DRUG; APOPTOTIC; BIOAPPLICATIONS; BIOLOGICAL EFFECTS; CELL RESPONSE; CELL STRUCTURE; CELL THERAPY; CELL VIABILITY; COMBINED EFFECT; EXTERNAL FIELDS; EXTERNAL STATIC MAGNETIC; HUMAN CELL LINES; HUMAN TUMOR CELLS; KEY FACTORS; MAGNETIC NANOPARTICLES; MAGNETIC NATURE; MAGNETIC STIMULATION; MICROARRAY ANALYSIS; PROLIFERATION;

CELL CULTURE; CELLS; MAGNETIC FIELDS; MICROARRAYS; SIGNAL TRANSDUCTION;

NANOPARTICLES;

BACTERIAL MAGNETIC NANOPARTICLE; CISPLATIN; MAGNETIC NANOPARTICLE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL GROWTH; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; INTERNALIZATION; MAGNETIC FIELD; MAGNETIC STIMULATION; MAGNETOSPIRILLUM; MICROARRAY ANALYSIS; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STATIC MAGNETIC FIELD;

CELL PROLIFERATION; CELL SURVIVAL; HELA CELLS; HUMANS; MAGNETIC FIELDS; MAGNETITE NANOPARTICLES; MAGNETOSPIRILLUM; MATERIALS TESTING;

BACTERIA (MICROORGANISMS);

EID: 84861221397     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.04.033     Document Type: Article

References (48)

1. Bhattarai S.R., Kc R.B., Kim S.Y., Sharma M., Khil M.S., Hwang P.H., et al. N-hexanoyl chitosan stabilized magnetic nanoparticles: implication for cellular labeling and magnetic resonance imaging. J Nanobiotechnol. 2008, 6(1):1-9.
2. Gupta A.K., Wells S. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans NanoBiosci. 2004, 3(1):66-73.
3. McBain S.C., Yiu H.H., Dobson J. Magnetic nanoparticles for gene and drug delivery. Int J Nanomedicine 2008, 3(2):169-180.
4. Villanueva A., Pdl Presa, Alonso J.M., Rueda T., Martínez A., Crespo P., et al. Hyperthermia HeLa cell treatment with silica-coated manganese oxide nanoparticles. J Phys Chem C 2010, 114:1976-1981.
5. Voltairas P.A., Fotiadis D.I., Michalis L.K. Hydrodynamics of magnetic drug targeting. J Biomech 2002, 35:813-821.
6. Smith C.A., de la Fuente J., Pelaz B., Furlani E.P., Mullin M., Berry C.C. The effect of static magnetic fields and tat peptides on cellular and nuclear uptake of magnetic nanoparticles. Biomaterials 2010, 31(15):4392-4400.
7. Wiskirchen J., Grönewäller E.F., Kehlbach R., Heinzelmann F., Wittau M., Rodemann H.P., et al. Long-term effects of repetitive exposure to a static magnetic field (1.5 T) on proliferation of human fetal lung fibroblasts. Magn Reson Med. 1999, 41:464-468.
8. Nakahara T., Yaguchi H., Yoshida M., Miyakoshi J. Effects of exposure of CHO-K1 cells to a 10-T static magnetic field. Radiology 2002, 224:817-822.
9. Wiskirchen J., Grönewäller E.F., Heinzelmann F., Kehlbach R., Rodegerdts E., Wittau M., et al. Human fetal lung fibroblasts: in vitro study of repetitve mangetic field exposure at 0.2, 1.0, and 1.5 T. Radiology 2000, 215:858-862.
10. Frankel R.B., Blakemore R.P., Wolfe R.S. Magnetite in freshwater magnetotactic bacteria. Science 1979, 203(30):1355-1356.
11. Mann S., Frankel R.B., Blakemore R.P. Structure morphology and crystal growth of bacterial magnetite. Nature 1984, 310(2):405-407.
12. Sakaguchi T., Burgess J.G., Matsunaga T. Magnetite formation by a sulphate-reducing bacterium. Nature 1993, 365(2):47-49.
13. Nakamura N., Matsunaga T. Highly sensitive detection of allergen using bacterial magnetic particles. Anal Chim Acta 1993, 281:585-589.
14. Balkwill D.L., Maratea D., Blakemore R.P. Ultrastructure of a magnetotactic spirillum. J Bacteriol 1980, 141(3):1399-1408.
15. Mandal D., Bolander M.E., Mukhopadhyay D., Sarkar G., Mukherjee P. The use of microorganisms for the formation of metal nanoparticles and their application. Appl Microbiol Biotechnol 2006, 69(5):485-492.
16. Staniland S., Williams W., Telling N., Van Der Laan G., Harrison A., Ward B. Controlled cobalt doping of magnetosomes in vivo. Nat Nanotechnology 2008, 3(3):158-162.
17. Blakemore R.P., Maratea D., Wolfe R.S. Isolation and pure culture of a freshwater magnetic spirillum in chemically defined medium. J Bacteriol 1979, 140(2):720-729.
18. Matsunaga T., Okamura Y., Tanaka T. Biotechnological application of nano-scale engineered bacterial magnetic particles. J Mater Chem 2004, 14(14):2099-2105.
19. Kim J.A., Lee H.J., Kang H.-J., Park T.H. The targeting of endothelial progenitor cells to a specific location within a microfluidic channel using magnetic nanoparticles. Biomed Microdevices 2008, 11(1):287-296.
20. Frankel R.B., Bazylinski D.A. Nanobiotechnology 2004, WILEY-VCH.
21. Krichevsky A., Smith M.J., Whitman L.J., Johnson M.B., Clinton T.W., Perry L.L., et al. Trapping motile magnetotactic bacteria with a magnetic recording head. J Appl Phys. 2007, 101(1):014701.
22. Kopp R.E., Kirschvink J.L. The identification and biogeochemical interpretation of fossil magnetotactic bacteria. Earth-Sci Rev 2008, 86(1-4):42-61.
23. Weiss B.P., Sam Kim S., Kirschvink J.L., Kopp R.E., Sankaran M., Kobayashi A., et al. Ferromagnetic resonance and low-temperature magnetic tests for biogenic magnetite. Earth Planet Sci Lett 2004, 224(1-2):73-89.
24. Hergt R., Hiergeist R., Zeisberger M., Schuler D., Heyen U., Hilger I., et al. Magnetic properties of bacterial magnetosomes as potential diagnostic and therapeutic tools. J Magn Magn Mater 2005, 293(1):80-86.
25. Bazylinski D.A., Frankel R.B. Magnetosome formation in prokaryotes. Nat reviews Microbiol 2004, 2(3):217-230.
26. Flies C.B., Peplies J., Schuler D. Combined approach for characterization of uncultivated magnetotactic bacteria from various aquatic environments. Appl Environ Microbiol 2005, 71(5):2723-2731.
27. Schüler D., Frankel R.B. Bacterial magnetosomes: microbiology, biomineralization and biotechnological applications. Appl Microbiol Biotechnol 1999, 52:464-473.
28. Moskowitz B.M. Biomineralization of magnetic minerals. Rev Geophys 1995, 33:123-128.
29. Dunin-Borkowski R.E., McCartney M.R., Pósfai M., Frankel R.B., Bazylinski D.A., Buseck P.R. Off-axis electron holography of magnetotactic bacteria: magnetic microstructure of strains MV-1 and MS-1. Eur J Mineral 2001, 13(4):671-684.
30. Schüler D. Formation of magnetosomes in magnetotactic bacteria. J Mol Microbiol Biotechnol 1999, 1:79-86.
31. Yang Y., Bauer C., Strasser G., Wollman R., Julien J.-P., Fuchs E. Integrators of the cytoskeleton that stabilize microtubules. Cell 1999, 98:229-238.
32. Chionna A., Dwikat M., Panzarini E., Tenuzzo B., Carlà E.C., Verri T., et al. Cell shape and plasma membrane alterations after static magnetic fields exposure. Eur J Histochem 2003, 47:299-308.
33. Dini L., Abbro L. Bioeffects of moderate-intensity static magnetic fields on cell cultures. Micron 2005, 36(3):195-217.
34. Sato K., Yamaguchi H., Miyamoto H., Kinouchi Y. Growth of human cultured cells exposed to a non-homogeneous static mangetic field generated by Sm-Co magnets. Biochim Biophys Acta 1992, 1136(3):231-238.
35. Muggia F.M. Recent updates in the clinical use of platinum compounds for the treatment of gyneclogic cancers. Semin Oncol 2004, 31:17-24.
36. Lane D.P. p53, guardian of the genome. Nature 1992, 358:15-16.
37. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 protein in the celluar response to DNA damage. Cancer Res 1991, 51:6304-6311.
38. Kuerbitz S.J., Plunkett B.S., Walsh W.V., Kastan M.B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992, 89:7491-7495.
39. Matlashewski G., Banks L., PIM D., Crawford L. Analysis of human p53 proteins and mRNA levels in normal and transformed cells. Eur J Biochem 1986, 154(3):665-672.
40. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136.
41. Rosen A.D. Mechanism of Action of moderate-intensity static magnetic fields on Bological systems. Cell Biochem Biophys 2003, 39:163-173.
42. New D.C., Wong Y.H. Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression. J Mol Signaling 2007, 2:2-16.
43. Teicher B.A., Fricker S.P. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 2010, 16(11):2927-2931.
44. Goldsmith Z.G., Dhanasekaran D.N. G protein regulation of MAPK networks. Oncogene 2007, 26(22):3122-3142.
45. Wilden P.A., Agazie Y.M., Kaufman R., Halenda S.P. ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways. Am J Physiol Heart Circ Physiol 1998, 275(4). H1209-H1H15.
46. Heo J.-I., Oh S.-J., Kho Y.-J., Kim J.-H., Kang H.-J., Park S.-H., et al. ERK mediates anti-apoptotic effect through phosphorylation and cytoplasmic localization of p21Waf1/Cip1/Sdi in response to DNA damage in normal human embryonic fibroblast (HEF) cells. Mol Biol Rep 2010, 38(4):2785-2791.
47. 2+ currents in rod and cone photoreceptors of the salamander retina. J Neurosci 2000, 20(3):929-936.
48. Gartzke J., Lange K. Cellular target of weak magnetic fields: ionic conduction along actin filaments of microvilli. Am J Physiol Cell Physiol 2002, 283. C1333-C1C46.